PV Bulletin

Voluntary Data Submission Pilot to Advance Innovative Alternatives to Animal Testing

The European Medicines Agency (EMA) has launched a voluntary data submission pilot for developers to present New Approach Methodologies (NAMs) data.

Primary source: View

PV Impact Brief

MonitoringConfidence: high

What changed

A voluntary data submission pilot has been initiated, enabling stakeholders to submit NAMs data for consideration independent of existing regulatory procedures.

Why it matters

This initiative promotes the use of innovative testing methodologies, potentially leading to reduced reliance on animal testing and more efficient regulatory decision-making.

Action needed

Stakeholders can submit NAMs data by completing the prescribed application form, available until Q3 2027.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Country Compliance
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 1, 2026

Full briefing

Practical implication

Stakeholders can submit NAMs data by completing the prescribed application form, available until Q3 2027.

The EMA's new pilot allows stakeholders to submit NAM data for tailored feedback, aiming to facilitate innovative alternatives to traditional animal testing.

What changed: A voluntary data submission pilot has been initiated, enabling stakeholders to submit NAMs data for consideration independent of existing regulatory procedures.

Why it matters: This initiative promotes the use of innovative testing methodologies, potentially leading to reduced reliance on animal testing and more efficient regulatory decision-making.

Practical implication: Stakeholders can submit NAMs data by completing the prescribed application form, available until Q3 2027.

View original source

  • Source: EMA - What's new
  • Published at source: 2026-09-01T13:48:00.000Z
  • Discovered by monitor: 2026-09-02T21:45:26.922Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicEuropean Medicines Agency (EMA) · European Union · Updated Sep 2, 2026

Prasugrel Viatris (previously Prasugrel Mylan)

Urgency: High

Ensure that all labeling and safety information reflects the updated product name 'Prasugrel Viatris' instead of 'Prasugrel Mylan'.

LabelingLabeling Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Labeling Lead, Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 2, 2026

MHRA and Manchester NHS partner on health innovation sandbox

Urgency: High

The program will implement collaborative processes for the evaluation of technologies, enhancing real-world evidence integration into signal management and impacting regulatory compliance workflows.

Signal ManagementCountry ComplianceRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 1, 2026

UK accelerates support for efforts to stop Ebola outbreak at source

Urgency: High

Operational support will now be increased for disease surveillance, health worker assistance, and community outreach based on the new funding and response framework.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicFDA · USA · Updated Sep 2, 2026

MAXMAN Coffee may be harmful due to hidden drug ingredients

Urgency: High

Enhanced monitoring for products with hidden drug ingredients is required, leading to increased need for rapid reporting and investigation of adverse events associated with similar products.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward